Bruce Roser

Stablepharma Ltd. is a British company that specializes in developing fridge-free vaccines to improve patient access to safe and effective treatment. The company's science team is based at Stablepharma's R&D center in Qube Technology Park, which is located 20 miles from an international airport. The company is based in Bath, UK. The team is led by Dr. Arcadio Garcia de Castro, the Chief Scientific Officer, and supported by Juana de la Torres, Senior R&D Manager, and the wider team. The company continues their work validating the high-temperature stability of vaccines. The company was founded in 2012 by Bruce Roser, who identified and patented the process of using trehalose to achieve a state of 'suspended animation' in a sugar glass, to thermally stabilize a range of vaccines. The CEO is Ozgur Tuncer.

Cambridge Biostability Ltd. manufactures vaccines and drugs. The firm's two platforms VitRIS and HydRIS offers pharmaceuticals, vaccines, and other biological products in thermo-stable, instantly-injectable formats. The company was founded by Dr Bruce Roser in 2003 and is headquartered in UK.